Topical medication utilization and health resources consumption in adult patients affected by psoriasis: findings from the analysis of administrative databases of local health units

References

• de KorteJSprangersMAMombersFMBosJDQuality of life in patients with psoriasis: a systematic literature reviewJ Investig Dermatol Symp Proc200492140147
   PubMed Web of Science ®Google Scholar
• GriffithsCEBarkerJNPathogenesis and clinical features of psoriasisLancet2007370958326327117658397
   PubMed Web of Science ®Google Scholar
• HuertaCRiveroERodríguezLAIncidence and risk factors for psoriasis in the general populationArch Dermatol2007143121559156518087008
   PubMedGoogle Scholar
• Ragnarson TennvallGHjortsbergCBjarnasonATreatment patterns, treatment satisfaction, severity of disease problems, and quality of life in patients with psoriasis in three Nordic countriesActa Derm Venereol201393444244523138500
   PubMed Web of Science ®Google Scholar
• NestleFOKaplanDHBarkerJPsoriasisN Engl J Med2009361549650919641206
   PubMed Web of Science ®Google Scholar
• ParisiRSymmonsDPGriffithsCEMAshcroftDMIdentification and Management of Psoriasis and Associated ComorbidiTy (IMPACT) Project TeamGlobal epidemiology of psoriasis: a systematic review of incidence and prevalenceJ Invest Dermatol2013133237738523014338
   PubMed Web of Science ®Google Scholar
• Il trattamento della psoriasi nell’adulto. Linee guida SNLG-SS [The treatment of psoriasis in adults. Guidelines SNLG-SS] Available from: http://www.snlg-iss.it/cms/files/LG_Psoriasi.pdfAccessed January 16, 2017
   Google Scholar
• National Clinical Guideline Centre (UK)Psoriasis: Assessment and Management of PsoriasisLondonRoyal College of Physicians (UK)2012 [cited 2015 Aug 24]. (National Institute for Health and Clinical Excellence: Guidance). Available from: http://www.ncbi.nlm.nih.gov/books/NBK247829/
   Google Scholar
• MenterAGottliebAFeldmanSRGuidelines of care for the management of psoriasis and psoriatic arthritis: section 1. Overview of psoriasis and guidelines of care for the treatment of psoriasis with biologicsJ Am Acad Dermatol200858582685018423260
   PubMed Web of Science ®Google Scholar
• MurphyGReichKIn touch with psoriasis: topical treatments and current guidelinesJ Eur Acad Dermatol Venereol201125Suppl 43821507077
   PubMed Web of Science ®Google Scholar
• ColomboGLDi MatteoSBrunoGGirolomoniGVenaGACalcipotriol and betamethasone dipropionate in the treatment of mild-to-moderate psoriasis: a cost-effectiveness analysis of the ointment versus gel formulationClinicoecon Outcomes Res201226126823028233
   PubMedGoogle Scholar
• MenterAKormanNJElmetsCAAmerican Academy of Dermatology Work GroupGuidelines of care for the management of psoriasis and psoriatic arthritis: section 6. Guidelines of care for the treatment of psoriasis and psoriatic arthritis: case-based presentations and evidence-based conclusionsJ Am Acad Dermatol201165113717421306785
   PubMed Web of Science ®Google Scholar
• MasonARMasonJCorkMDooleyGHancockHTopical treatments for chronic plaque psoriasisCochrane Database Syst Rev20133283CD00502823543539
   PubMed Web of Science ®Google Scholar
• PerroneVSangiorgiDBudaSDegli EspostiLDisease progression and health care resource consumption in patients affected by hepatitis C virus in real practice settingClinicoecon Outcomes Res2016859159727789966
   PubMed Web of Science ®Google Scholar
• Degli EspostiLSangiorgiDBudaSDegli EspostiEScaglioneFTherapy discontinuation or substitution in patients with cardiovascular disease, switching among different products of the same off-patent active substance: a ‘real-world’ retrospective cohort studyBMJ Open2016611e012003
   PubMed Web of Science ®Google Scholar
• Agenzia Italiana del Farmaco (AIFA)Guideline for the classification and conduction of the observational studies on medicines2010 Available from: https://www.agenziafarmaco.gov.it/ricclin/sites/default/files/files_wysiwyg/files/CIRCULARS/Circular%2031st%20May%202010.pdfAccessed January 16, 2017
   Google Scholar
• ChaptiniCQuinnSMarshmanGDurable dermatology life quality index improvements in patients on biologics associated with psoriasis areas and severity index: a longitudinal studyAustralas J Dermatol2016573e72e7526010650
   PubMed Web of Science ®Google Scholar
• HernánzJMSánchez-RegañaMIzuRMendiolaVGarcía-CalvoCClinical and therapeutic evaluation of patients with moderate to severe psoriasis in Spain: the secuence studyActas Dermosifiliogr201210310897904
   Google Scholar
• GonnellaJSLouisDZGozumMVCallahanCABarnesCADisease staging clinical and coded criteria. Version 5.26Ann Arbor, MIThomson Medstat2010
   Google Scholar
• European Medicine Agency (EMA)Calcipotriol/Betamethasone – Summary of Product Characteristics Available from: http://www.ema.europa.eu/docs/en_GB/document_library/Referrals_document/Daivobet_30/WC500094997.pdfAccessed January 16, 2017
   Google Scholar
• SvedbomADalénJMamoloCCappelleriJCPeterssonIFStåhleMTreatment patterns with topicals, traditional systemics and biologics in psoriasis – a Swedish database analysisJ Eur Acad Dermatol Venereol201529221522324813476
   PubMed Web of Science ®Google Scholar
• Ramirez-FortMKLevinAAAuSCGottliebABContinuous versus intermittent therapy for moderate-to-severe psoriasisClin Exp Rheumatol2013314 Suppl 78S63S7024129141
   PubMed Web of Science ®Google Scholar
• EissingLRadtkeMAZanderNAugustinMBarriers to guideline-compliant psoriasis care: analyses and conceptsJ Eur Acad Dermatol Venereol201630456957526538533
   PubMed Web of Science ®Google Scholar
• SticherlingMEickeCAngerTPracticability of combined treatment with calcipotriol/betamethasone gel (Daivobet® Gel) and improvement of quality of life in patients with psoriasisJ Dtsch Dermatol Ges201311542042723437972
   PubMed Web of Science ®Google Scholar
• HendriksAGKeijsersRRde JongEMSeygerMMvan de KerkhofPCEfficacy and safety of combinations of first-line topical treatments in chronic plaque psoriasis: a systematic literature reviewJ Eur Acad Dermatol Venereol201327893195123279069
   PubMed Web of Science ®Google Scholar
• KoyamaGLiuJScaffidiAKhazraeeMEpsteinBNovel Approaches to topical psoriasis therapyInt J Pharm Compd201519535736526775441
   PubMedGoogle Scholar
• RogalskiCCalcipotriol/betamethasone for the treatment of psoriasis: efficacy, safety, and patient acceptabilityPsoriasis Targets Ther2015597107
   Google Scholar
• NeriLMiracapilloATreatment adherence and real-life effectiveness of topical therapy in patients with mild or moderate psoriasis: uptake of scientific evidence in clinical practice and dermatologists’ preferences for alternative treatment optionsG Ital Dermatol Venereol20151501192625521808
   PubMed Web of Science ®Google Scholar
• MorrillJAShresthaMGrantRWBarriers to the treatment of hepatitis C. Patient, provider, and system factorsJ Gen Intern Med200520875475816050887
   PubMed Web of Science ®Google Scholar
• VangeliEBakhshiSBakerAA systematic review of factors associated with non-adherence to treatment for immune-mediated inflammatory diseasesAdv Ther20153211983102826547912
   PubMed Web of Science ®Google Scholar
• OsterbergLBlaschkeTAdherence to medicationN Engl J Med2005353548749716079372
   PubMed Web of Science ®Google Scholar
• BewleyAPageBMaximizing patient adherence for optimal outcomes in psoriasisJ Eur Acad Dermatol Venereol201125Suppl 491421507078
   PubMed Web of Science ®Google Scholar
• McDonaldHPGargAXHaynesRBInterventions to enhance patient adherence to medication prescriptions: scientific reviewJAMA2002288222868287912472329
   PubMed Web of Science ®Google Scholar
• DevauxSCastelaAArchierEAdherence to topical treatment in psoriasis: a systematic literature reviewJ Eur Acad Dermatol Venereol201226Suppl 3616722512682
   PubMed Web of Science ®Google Scholar
• FeldmanSRHornEJBalkrishnanRInternational Psoriasis CouncilPsoriasis: improving adherence to topical therapyJ Am Acad Dermatol20085961009101618835062
   PubMed Web of Science ®Google Scholar
• NelsonPABarkerZGriffithsCECordingleyLChew-GrahamCAIMPACT Team‘On the surface’: a qualitative study of GPs’ and patients’ perspectives on psoriasisBMC Fam Pract20131415824138455
   PubMed Web of Science ®Google Scholar
• ThorneloeRJBundyCGriffithsCEAshcroftDMCordingleyLAdherence to medication in patients with psoriasis: a systematic literature reviewBr J Dermatol20131681203122963128
   PubMed Web of Science ®Google Scholar
• BewleyABurrageDMErsserSJHansenMWardCIdentifying individual psychosocial and adherence support needs in patients with psoriasis: a multinational two-stage qualitative and quantitative studyJ Eur Acad Dermatol Venereol201428676377023663069
   PubMed Web of Science ®Google Scholar
• DaudénEBewleyALambertJGirolomoniGCambazardFReichKExpert recommendations: the use of the fixed combination calcipotriol and betamethasone dipropionate gel for the topical treatment of psoriasisJ Eur Acad Dermatol Venereol201428Suppl 2223224684740
   PubMed Web of Science ®Google Scholar
• GirolomoniGVenaGAAyalaFConsensus on the use of the fixed combination calcipotriol/betamethasone dipropionate in the treatment of plaque psoriasisG Ital Dermatol Venereol2012147660962423149707
   PubMed Web of Science ®Google Scholar
• VakirlisEKastanisAIoannidesDCalcipotriol/betamethasone dipropionate in the treatment of psoriasis vulgarisTher Clin Risk Manag20084114114818728704
   PubMedGoogle Scholar
• FeldmanSRBurudpakdeeCGalaSNanavatyMMallyaUGThe economic burden of psoriasis: a systematic literature reviewExpert Rev Pharmacoecon Outcomes Res201414568570525052261
   PubMed Web of Science ®Google Scholar
• SvedbomADahlénJMamoloCEconomic burden of psoriasis and potential cost offsets with biologic treatment: a Swedish register analysisActa Derm Venereol201696565165726716136
   PubMed Web of Science ®Google Scholar
• Burgos-PolRMartínez-SesmeroJMVentura-CerdáJMElíasICalotoMTCasadoMÁThe cost of psoriasis and psoriatic arthritis in 5 European countries: a systematic reviewActas Dermosifiliogr2016107757759027316590
   PubMed Web of Science ®Google Scholar
• PearceDJThomasCGFleischerABJrFeldmanSRThe cost of psoriasis therapies: considerations for therapy selectionDermatol Nurs200416542142843215624706
   PubMedGoogle Scholar